cis-3-Hexenyl anthranilate
Common Name: |
cis-3-Hexenyl anthranilate |
IUPAC Name: |
[(Z)-hex-3-enyl] 2-aminobenzoate |
Molecular Formula: |
C13H17NO2 |
SMILES: |
CCC=CCCOC(=O)C1=CC=CC=C1N |
Inchi: |
1S/C13H17NO2/c1-2-3-4-7-10-16-13(15)11-8-5-6-9-12(11)14/h3-6,8-9H,2,7,10,14H2,1H3/b4-3- |
Inchi Key: |
VZWCCPAVZNSCEO-ARJAWSKDSA-N |
Cas No: |
65405-76-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
219.28 |
Mass (g/mol) |
219.126 |
Molar Refractivity |
65.69 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
52.32 |
Hetero Atoms |
3 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
160.00 @ 5.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.000089 |
Vapor Density (Air =1) |
>1 |
Fraction Csp3 |
0.31 |
LogP |
2.782 |
iLOGP |
2.77 |
XLOGP3 |
3.97 |
WLOGP |
2.79 |
MLOGP |
2.70 |
ESOL Log S |
-3.58 |
ESOL Solubility (mg/ml) |
0.057 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.77 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.43 |
Silicos-IT Solubility (mg/ml) |
0.08 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.82 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.995 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.679 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |